Essential cookies by default. The browser ID, load-time metrics and error replays only run if you choose "Accept all".
Head-to-head evidence comparison — which supplement is right for you?
Potassium vs Vitamin K2: Potassium has the stronger overall evidence (8.5 vs 5/10); they're alternatives for support heart health — the best pick depends on your goals. Take the 2-minute quiz for a pick tailored to your goals.
Potassium wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Helped
2 of 3 studies with measurable effects showed benefit.
Top outcomes
Verdict
Too few graded studies
1 of 1 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Potassium and Vitamin K2 have evidence — compare verdict strength side-by-side.
No matched minimum effective dose established here
The absence of a published dose limit does not mean that larger amounts are safe. Check potassium supplements with a clinician or pharmacist if you have kidney disease or take medicines that affect potassium.
With food to reduce GI upset, Spread throughout day, During/after exercise for athletes
Potassium Citrate or Potassium Gluconate
A source-matched dose range is not available for this product and use.
With a meal containing fat
MK-7 (menaquinone-7)
and 10 more not shown
2-4 weeks
1-2 weeks
Long-term
With excess or kidney issues
4-12 weeks
1-3 years
1-3 years
Effect of changes in potassium intake on blood pressure: a dose–response meta-analysis of randomized clinical trials (2000–2024)
Clinical Kidney Journal (2025) · Meta-Analysis
Our meta-analysis included 10 RCTs, comprising 4 studies on subjects without hypertension and 6 studies on subjects with hypertension.
Magnesium and Potassium Supplementation for Systolic Blood Pressure Reduction in the General Normotensive Population: A Systematic Review and Subgroup Meta-Analysis for Optimal Dosage and Treatment Length
Nutrients (2024) · Meta-Analysis
Both supplements demonstrated greater reductions in SBP for the general population at lower dosages and longer treatment durations.
Sex-specific associations between sodium and potassium intake and overall and cause-specific mortality: a large prospective U.S. cohort study, systematic review, and updated meta-analysis of cohort studies
BMC medicine (2024) · Meta-Analysis · n=416104
Prospective analysis of 237,036 men and 179,068 women in the NIH-AARP Diet and Health Study, plus an updated meta-analysis of cohort studies.
Vitamins K2 and D3 Improve Long COVID, Fungal Translocation, and Inflammation: Randomized Controlled Trial
Nutrients (2025) · RCT · n=151
The median age was 46 years; 71% were female and 29% were non-white.
The effect of vitamin K2 supplementation on bone turnover biochemical markers in postmenopausal osteoporosis patients: a systematic review and meta-analysis
Frontiers in endocrinology (2025) · Meta-Analysis · n=2570
Vitamin K2 (VK2) increased osteocalcin (OC; MD 1.86, 95% CI 1.17-2.56) and bone-specific alkaline phosphatase (BAP; MD 1.49, 95% CI 0.98-2.00).
Vitamin K2 in Managing Nocturnal Leg Cramps: A Randomized Clinical Trial
JAMA internal medicine (2024) · RCT · n=199
Of the 199 enrolled individuals, 108 (54.3%) were female, and the mean (SD) age was 72.3 (5.5) years.
No dose-response chart is shown because we have not yet verified enough comparable dose-specific estimates and their uncertainty to support one.
In a 1-year randomised trial of 311 Chinese men and postmenopausal women, 90 μg of MK-7 a day slowed femoral neck bone loss in the postmenopausal women and 50 μg did not, with no effect in men (PMID 32060566). In a 3-year randomised placebo-controlled trial of 244 healthy postmenopausal women, 180 μg a day reduced the decline in bone density at the lumbar spine and femoral neck but not the total hip (PMID 23525894). In a 3-year randomised placebo-controlled trial of 142 postmenopausal women with osteopenia, 375 μg a day with calcium and vitamin D did not change bone density at any site (PMID 33030563). The curve stays flat above 90 μg because no trial compared 90 μg with a higher dose, and the 375 μg trial found no effect. The cited BMD meta-analyses do not state a dose and mostly pool menaquinone-4 trials, so they are not plotted.
Potassium has a higher evidence score (8.5/10 vs 5/10) and wins in 2 of 3 categories.
For support heart health, Potassium has a higher relevance score (68 vs 30).
No documented interaction was found in the data searched. This does not establish that this exact combination is safe.
Who actually needs electrolytes (and who doesn’t), what matters (sodium), and LMNT vs alternatives.
Which supplements clash with blood thinners, thyroid meds, antibiotics & more — and what to do.
Hot flashes, bone, sleep, muscle — the basics that hold up vs the phytoestrogen hype.
Worth it if you’re deficient (and many are) — dosing, testing, D3 vs D2, and the K2 question.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.